Miladys Limonta‐Fernández
-
- SARS-CoV-2 and COVID-19 Research 3
-
- Hepatitis C virus research 2
-
- Immunotherapy and Immune Responses 4
-
- vaccines and immunoinformatics approaches 4
- Protein purification and stability 2
-
- Hepatitis B Virus Studies 4
- Cervical Cancer and HPV Research 2
-
- Vaccine Coverage and Hesitancy 2
Miladys Limonta‐Fernández
17 papers receiving 128 citations
Peers
Comparison fields: 5 of 50
- Virology 17
- Infectious Diseases 50
- Hepatology 19
- Modeling and Simulation 11
- Immunology 33
Countries citing papers authored by Miladys Limonta‐Fernández
This map shows the geographic impact of Miladys Limonta‐Fernández's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miladys Limonta‐Fernández with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miladys Limonta‐Fernández more than expected).
Fields of papers citing papers by Miladys Limonta‐Fernández
This network shows the impact of papers produced by Miladys Limonta‐Fernández. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miladys Limonta‐Fernández. The network helps show where Miladys Limonta‐Fernández may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Miladys Limonta‐Fernández, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2022 | 19 | |
| 5 | 2022 | 13 | |
| 6 | 2019 | 4 | |
| 7 | 2018 | 3 | |
| 8 | 2018 | 3 | |
| 9 | 2018 | 1 | |
| 10 | 2017 | 4 | |
| 11 | 2015 | 5 | |
| 12 | 2013 | 18 | |
| 13 | 2013 | 6 | |
| 14 | Estudios fisiológicos y nutricionales de la Escherichia coli y la combinación novedosa de métodos de separación permiten obtener ADN plasmídico con alta pureza y homogeneidad para su uso en terapia génica | 2012 | 1 |
| 15 | 2009 | 19 | |
| 16 | 1999 | 9 | |
| 17 | 1994 | 16 | |
| 18 | 1989 | 5 | |
| 19 | Uso del interferón leucocitario durante una epidemia de dengue hemorrágico (virus tipo II) en Cuba | 1984 | 3 |
About Miladys Limonta‐Fernández
Miladys Limonta‐Fernández is a scholar working on Immunology, Infectious Diseases and Hepatology, having authored 19 papers that have together received 133 indexed citations. Recurring topics across this work include vaccines and immunoinformatics approaches (4 papers), Immunotherapy and Immune Responses (4 papers), Hepatitis B Virus Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Cervical Cancer and HPV Research (2 papers), Protein purification and stability (2 papers), Hepatitis C virus research (2 papers) and Vaccine Coverage and Hesitancy (2 papers). The work is most often cited by research in Virology (17 citations), Infectious Diseases (50 citations) and Hepatology (19 citations). Miladys Limonta‐Fernández has collaborated with scholars based in Cuba, Spain and Chile. Frequent co-authors include Santiago Dueñas‐Carrera, Martín Fraga, Nika Lendero Krajnc, Merardo Pujol, Ania Cabrales, Mario Pablo Estrada, Omar Farnós, Yssel Mendoza‐Marí, Francisco Parra and José M. Martı́n-Alonso. Their work appears in journals such as PLoS ONE, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.